World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
53
Citations
19290
World Ranking
15905
National Ranking
6

Overview

Iris Behrmann is affiliated with the University of Luxembourg in Luxembourg and works primarily within the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their research spans several specialized subfields, including Molecular Biology, Immunology, Cancer Research, Hepatology, and Oncology.

Their work mainly focuses on topics related to extracellular vesicles in disease, microRNA in disease regulation, monoclonal and polyclonal antibodies research, glycosylation and glycoproteins research, RNA modifications and cancer, liver disease diagnosis and treatment, and liver diseases and immunity.

Recent publications by Behrmann demonstrate an emphasis on cancer, melanoma cells, and liver diseases, reflecting the multidisciplinary nature of their research. Notable papers include:

  • Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles, 2020, published in Cancers
  • Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells, 2020, published in International Journal of Molecular Sciences
  • Altered profiles of circulating cytokines in chronic liver diseases (NAFLD/HCC): Impact of the PNPLA3 I148M risk allele, 2023, published in Hepatology Communications
  • Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types, 2020, published in Journal of Molecular Biology
  • Ferroptosis susceptibility of melanoma cells: dependence on cell-type, acquired drug resistance, and medium composition, 2024, published in bioRxiv (Cold Spring Harbor Laboratory)

Behrmann frequently publishes in the venue bioRxiv (Cold Spring Harbor Laboratory), alongside contributions to Cancers, Hepatology Communications, International Journal of Molecular Sciences, and Journal of Molecular Biology.

They have collaborated extensively with several researchers, with frequent coauthors including:

  • Mélanie Kirchmeyer
  • Stephanie Kreis
  • Claude Haan
  • Anthoula Gaigneaux
  • Christiane Margue

Best Publications

  • Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

    Peter C Heinrich;Iris Behrmann;Serge Haan;Heike M Hermanns

  • Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.

    Frank C. Kischkel;Stefan Hellbardt;Iris Behrmann;Matthias Germer

  • INTERLEUKIN-6-TYPE CYTOKINE SIGNALLING THROUGH THE GP130/JAK/STAT PATHWAY

    Peter C. Heinrich;Iris Behrmann;Gerhard Müller-Newen;Fred Schaper

  • Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.

    A. Oehm;I. Behrmann;Werner Falk;M. Pawlita

  • Regulation of apoptosis in the immune system.

    Peter H. Krammer;Iris Behrmann;Peter Daniel;Jens Dhein

  • The Role of APO-1-Mediated Apoptosis in the Immune System

    Peter H. Krammer;Jens Dhein;Henning Walczak;Iris Behrmann

  • SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130

    Ute Lehmann;Jochen Schmitz;Manuela Weissenbach;Radoslaw M. Sobota

  • A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background

    Claude Haan;Iris Behrmann

  • STAT3 is constitutively activated in Hodgkin cell lines

    Dieter Kube;Dieter Kube;Dieter Kube;Udo Holtick;Udo Holtick;Udo Holtick;Martina Vockerodt;Martina Vockerodt;Martina Vockerodt;Tahamtan Ahmadi;Tahamtan Ahmadi;Tahamtan Ahmadi

  • Jaks and cytokine receptors--an intimate relationship.

    Claude Haan;Stephanie Kreis;Christiane Margue;Iris Behrmann

  • Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors.

    Claude Haan;Catherine Rolvering;Friedrich Raulf;Manuela Kapp

  • Signatures of MicroRNAs and Selected MicroRNA Target Genes in Human Melanoma

    Demetra Philippidou;Martina Schmitt;Dirk Moser;Christiane Margue

  • Structure of the human APO-1 gene

    Iris Behrmann;Henning Walczak;Peter H. Krammer

  • Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.

    Iris Behrmann;Susanne Wallner;Waraporn Komyod;Peter C. Heinrich

  • Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1

    Marcin Kortylewski;Peter C. Heinrich;Andrzej Mackiewicz;Ute Schniertshauer

  • MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties.

    Martina Schmitt;Christiane Margue;Iris Behrmann;Stephanie Kreis

  • Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells

    Martina J Schmitt;Demetra Philippidou;Susanne E Reinsbach;Christiane Margue

  • Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers.

    Gregor Bahrenberg;Iris Behrmann;Andreas Barthel;Paul Hekerman

  • Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase.

    Iris Behrmann;Tanja Smyczek;Peter C. Heinrich;Hildegard Schmitz-Van de Leur

  • The Matrix Metalloproteinase 9 (MMP-9) Hemopexin Domain Is a Novel Gelatin Binding Domain and Acts as an Antagonist

    Elke Roeb;Karin Schleinkofer;Thomas Kernebeck;Stephan Pötsch

Frequent Co-Authors

Peter C. Heinrich
Peter C. Heinrich University of Freiburg
Fred Schaper
Fred Schaper Otto-von-Guericke University Magdeburg
Gerhard Müller-Newen
Gerhard Müller-Newen RWTH Aachen University
Peter H. Krammer
Peter H. Krammer German Cancer Research Center
Frank Lammert
Frank Lammert Saarland University
Jan Tavernier
Jan Tavernier Ghent University
Peter T. Daniel
Peter T. Daniel Max Delbrück Center for Molecular Medicine
Klaus-Michael Debatin
Klaus-Michael Debatin University of Ulm
Henning Walczak
Henning Walczak University College London
Nobuyuki Kato
Nobuyuki Kato Okayama University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Iris Behrmann

Trending Scientists

Recently Published Articles